Eli Lilly, Purdue University Announce Five-Year Strategic Research Collaboration

Eli Lilly and Company said Thursday that it and Purdue University today have signed a five-year strategic collaboration to conduct life science research. Eli Lilly will provide up to $52 million for research focus areas that include developing improved delivery of injectable medicines with the goals of reducing pain, decreasing the number of injections, and enabling better patient compliance and overall health.

The research will also focus on developing predictive models for clinical success that reduce risks associated with investing in drug development, and more effectively predict the outcome of new therapies in humans.

Leave a Comment